Company intelligence / Profile preview

Research Innovation

San Francisco, California, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Research Innovation is a biotechnology company focused on the discovery and development of novel therapeutic agents for oncology and rare diseases. The company leverages its expertise in small molecule chemistry and monoclonal antibody engineering to target key pathways in disease progression. Research Innovation also provides contract research services to partner organizations, facilitating the advancement of early-stage drug candidates. With a commitment to scientific excellence, the company aims to address significant unmet medical needs through innovative research and strategic collaborations.

Therapeutic areas: Rare DiseasesOncology
Modalities: Small moleculeMonoclonal antibodyBiologic
Industry: Biotech

Beyond the preview

Go deeper on Research Innovation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Research Innovation.

Explore the full profile